Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China flag China · Delayed Price · Currency is CNY
34.17
-1.18 (-3.34%)
Apr 29, 2026, 3:04 PM CST

SHE:002940 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 2021 - 2017
Cash & Equivalents
687.41697.38859.75735.47688.91
Upgrade
Trading Asset Securities
102.2636.041069.359.6
Upgrade
Cash & Short-Term Investments
789.67733.42869.75804.76748.51
Upgrade
Cash Growth
7.67%-15.68%8.08%7.52%-12.36%
Upgrade
Accounts Receivable
218.89234.32244.86295.51301.32
Upgrade
Other Receivables
2.719.8521.456.7717.27
Upgrade
Receivables
221.6244.18266.31302.28318.59
Upgrade
Inventory
447.47503.79393.44293.23299.6
Upgrade
Other Current Assets
27.1117.4832.4351.699.25
Upgrade
Total Current Assets
1,4861,4991,5621,4521,376
Upgrade
Property, Plant & Equipment
617.28603.86615.8445.7474.63
Upgrade
Long-Term Investments
304.84304.7301.41302.15147.34
Upgrade
Goodwill
312.94312.94312.9421.9821.98
Upgrade
Other Intangible Assets
123.57133.55139.1438.7840.05
Upgrade
Long-Term Deferred Tax Assets
39.1250.0632.7722.4420.65
Upgrade
Long-Term Deferred Charges
52.6449.4835.060.981.6
Upgrade
Other Long-Term Assets
14.5721.0720.95312.091.36
Upgrade
Total Assets
2,9512,9753,0202,5962,084
Upgrade
Accounts Payable
434.09485.45402.49320.45335.97
Upgrade
Accrued Expenses
44.77120.24130.41220.56218.67
Upgrade
Short-Term Debt
137.06163.37134.9171.941.76
Upgrade
Current Portion of Long-Term Debt
69.7420.2130.425.02-
Upgrade
Current Portion of Leases
--0.26--
Upgrade
Current Income Taxes Payable
11.75.579.34-2.88
Upgrade
Current Unearned Revenue
10.4132.3118.7241.6731.9
Upgrade
Other Current Liabilities
105.2716.395.458.954.1
Upgrade
Total Current Liabilities
813.03843.54731.97788.59595.29
Upgrade
Long-Term Debt
242.26303.5423.95150-
Upgrade
Long-Term Unearned Revenue
17.6416.7817.859.7313.3
Upgrade
Long-Term Deferred Tax Liabilities
10.6712.2913.951.60.06
Upgrade
Total Liabilities
1,0841,1761,188949.93608.64
Upgrade
Common Stock
201.73201.73201.73139.1295.95
Upgrade
Additional Paid-In Capital
708.28684.01723.84782.91824.87
Upgrade
Retained Earnings
794.22712.9674.51577.87478.74
Upgrade
Treasury Stock
-84.1-74.5-20.12--63.34
Upgrade
Comprehensive Income & Other
7.156.46.252.752.64
Upgrade
Total Common Equity
1,6271,5311,5861,5031,339
Upgrade
Minority Interest
239.94267.87246.07143.5136.08
Upgrade
Shareholders' Equity
1,8671,7981,8321,6461,475
Upgrade
Total Liabilities & Equity
2,9512,9753,0202,5962,084
Upgrade
Total Debt
449.05487.08589.52346.961.76
Upgrade
Net Cash (Debt)
340.61246.34280.23457.8746.75
Upgrade
Net Cash Growth
38.27%-12.10%-38.79%-38.69%-11.34%
Upgrade
Net Cash Per Share
1.681.231.402.303.74
Upgrade
Filing Date Shares Outstanding
211.69196.89199.71197.4197.4
Upgrade
Total Common Shares Outstanding
211.69196.89199.71197.4197.4
Upgrade
Working Capital
672.82655.33829.96663.37780.67
Upgrade
Book Value Per Share
7.697.777.947.616.78
Upgrade
Tangible Book Value
1,1911,0841,1341,4421,277
Upgrade
Tangible Book Value Per Share
5.635.515.687.306.47
Upgrade
Buildings
-447.5435.42314.48319.46
Upgrade
Machinery
-640.01628.95467.67439.73
Upgrade
Construction In Progress
-49.622.5225.3329.94
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.